Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales

Comments
Loading...

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 250 points on Wednesday.

The Dow traded up 0.27% to 44,146.86 while the NASDAQ rose 1.29% to 20,010.85. The S&P 500 also rose, gaining, 0.70% to 6,091.74.

Check This Out: Top 3 Health Care Stocks That Could Blast Off This Quarter

Leading and Lagging Sectors

Information technology shares surged by 2.5% on Wednesday.

In trading on Wednesday, utilities shares fell by 1.5%.

Top Headline

Abbott Laboratories ABT reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion.

Adjusted diluted earnings per share were $1.34, in line with the analyst estimates and management consensus of $1.31-$1.37, up from $1.19 a year ago.

Abbott projects full-year 2025 adjusted EPS of $5.05-$5.25 versus a consensus of $5.16, with organic sales growth of 7.5%- 8.5% and an adjusted operating margin of 23.5%- 24.0%. Abbott Laboratories expects first quarter 2025 adjusted EPS of $1.05-$1.09 versus consensus of $1.11.

Equities Trading UP
                       

  • Blackboxstocks Inc. BLBX shares shot up 101% to $3.39 after the company announced a $250K securities purchase agreement and is anticipating a potential merger.
  • Shares of Absci Corporation ABSIgot a boost, surging 26% to $4.0450 after Needham initiated coverage with a Buy rating and a $9 price target.
  • ImmunoPrecise Antibodies Ltd. IPA shares were also up, gaining 30% to $0.6396 after the company announced it developed a new class of GLP-1 therapies using its LENS platform.

Equities Trading DOWN

  • Agilysys, Inc. AGYS shares dropped 21% to $100.00 after the company reported worse-than-expected third-quarter sales results and issued FY25 revenue guidance below estimates.
  • Shares of Hepion Pharmaceuticals, Inc. HEPA were down 61% to $0.1265 after the company announced a $9 million public offering.
  • Lisata Therapeutics, Inc. LSTA was down, falling 30% to $2.72 after the company announced preliminary cohort data from its Phase 2 Ascend trial.

Commodities

In commodity news, oil traded down 0.4% to $75.55 while gold traded up 0.4% at $2,770.40.

Silver traded down 0.5% to $31.33 on Wednesday, while copper fell 1% to $4.2985.

Euro zone

European shares were mostly higher today. The eurozone's STOXX 600 surged 0.39%, Germany's DAX 40 rose 1.01% and France's CAC 40 gained 0.86%. Spain's IBEX 35 Index fell 0.37%, while London's FTSE 100 fell 0.04%.

Asia Pacific Markets

Asian markets closed mixed on Wednesday, with Japan's Nikkei 225 gaining 1.58%, China's Shanghai Composite Index falling 0.89%, Hong Kong's Hang Seng Index falling 1.63% and India's BSE Sensex gaining 0.75%.

Economics

U.S. mortgage applications rose 0.1% from the previous week in the week ending Jan. 17.

Now Read This:

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!